# Gripable

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gripable

- Industry: Medical Devices & Equipment
- Headquarters: London, UK
- Website: www.gripable.co
- Total disclosed funding: $16M
- Latest round: Series A (Mar 28, 2022)
- Investors on record: 5

## About

Based in the UK, Gripable Limited develops advanced rehabilitation technologies, focusing on enhancing patient recovery through innovative digital devices designed for upper limb assessment and training.Founded in 2017 in London, UK, Gripable Limited specializes in rehabilitation technology, specifically the GripAble Pro device. The company’s founders include Mike Mace and Paul Rinne, with Paul Rinne currently serving as CEO. In March 2022, Gripable Limited raised GBP 8.26 million in Series A funding, bringing the total amount raised to GBP 8.26 million and valuing the company at GBP 20.63 million post-money. The company has completed 5 deals to date, with its most recent deal occurring on 28 March 2022.GripAble's primary offering is the GripAble Pro, a digital device designed for the assessment and training of upper limb functions. This device serves various users, including therapists in neurological, pediatric, and musculoskeletal rehabilitation, facilitating recovery in both clinical and community settings. GripAble Pro tracks essential hand movements while connecting to a mobile application that provides real-time feedback and gamified exercises, currently marketed to healthcare professionals in North America.GripAble generates revenue primarily through direct sales of its GripAble Pro device to healthcare providers, including hospitals and rehabilitation centers. The pricing strategy emphasizes a high-quality product that is effective for rehabilitation, although specific pricing details are not disclosed. The company plans to enter the direct-to-consumer market, allowing patients to acquire the device through prescriptions, and aims to build partnerships with healthcare professionals to enhance patient outcomes.In March 2022, Gripable Limited raised GBP 8.26 million in Series A funding, co-led by new investors IP Group and Parkwalk Advisors. The company plans to utilize this funding to enhance end-to-end patient care and connect patients to personal home-based clinics. Gripable is expected to focus on designing upcoming products that complement its current offerings, while also targeting expansion into additional markets by the end of 2023.

## Funding rounds

- Series A, Mar 28, 2022, $11M — Longview Innovation, Parkwalk Advisors
- Seed, Dec 24, 2020, $2.1M — Oxford Technology Management, Parkwalk Advisors, Imperial College London, Triple Point Investment Management
- Seed, Apr 3, 2019, $2.4M — Triple Point Investment Management
- Seed, Sep 19, 2017, $0.2M — Oxford Technology Management

## Investors

- Oxford Technology Management (https://capitalatlas.ai/funds/oxford-technology-management) — Seed
- Triple Point Investment Management (https://capitalatlas.ai/funds/triple-point-investment-management) — Seed
- Parkwalk Advisors (https://capitalatlas.ai/funds/parkwalk-advisors) — Seed, Series A
- Imperial College London — Seed
- Longview Innovation (https://capitalatlas.ai/funds/longview-innovation) — Series A